This pilot study is exploring how Transcranial Magnetic Stimulation (TMS) to the cerebellum (a part of your brain that helps with movement and balance) might affect brain and thinking functions in people with schizophrenia. Researchers will use a device called MagVenture Mag Pro R30 to deliver TMS. You could be eligible if you are 18-60 years old and have a diagnosis of schizophrenia spectrum disorder. The main goal is to see if cerebellar function improves after 2 and 4 weeks of treatment. This study is currently recruiting 40 participants, but its overall status is unclear.

Study design

This is a single-site, randomized, sham-controlled study involving 40 participants with schizophrenia. Participants will be randomly assigned to receive either active TMS or a sham (inactive) TMS.

What's involved

Participants will receive TMS five days a week for four consecutive weeks. You will have fMRI scans (brain imaging), clinical assessments, and cognitive tests at the beginning, after two weeks, and after four weeks.

Compensation

Not stated in the trial record.

Follow-up

Cerebellar function will be measured at the end of the 2nd week and 4th week of the study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.